CNN  |  May 25, 2018

Dr. Daniel R. Lucey, a spokesman for the Infectious Diseases Society of America and an adjunct professor of medicine-infectious diseases at Georgetown University Medical Center, explained that ZMapp, an immune-based antibody treatment that can be given to people who are already sick with Ebola, is one such experimental treatment.

Read more here.